ET743-OVA-301
Laufzeit: 01.01.2005 - 31.12.2008
Kurzfassung
An open-label multicenter randomized Phase 3 study comparing the combination of DOXIL/CAELYX and YONDELIS with DOXIL/CAELYX alone in subjects with advanced relapsed ovarian cancer
Laufzeit: 01.01.2005 - 31.12.2008
An open-label multicenter randomized Phase 3 study comparing the combination of DOXIL/CAELYX and YONDELIS with DOXIL/CAELYX alone in subjects with advanced relapsed ovarian cancer
